<DOC>
	<DOCNO>NCT02458079</DOCNO>
	<brief_summary>Treatment severe alcoholic hepatitis patient eligible steroid therapy dilemma . Pentoxyfilline show improvement outcome per current study liver transplantation great risk recidivism difficult treat cohort patient . Dysbiosis forms central role severe alcoholic hepatitis patient modulation gut microbiota way healthy donor fecal transplantation could prove novel way treat patient ineligible standard therapy . This study utilize correction dysbiosis severe alcoholic hepatitis survey outcomes respect survival liver disease severity score .</brief_summary>
	<brief_title>Pentoxyphilline Versus Fecal Microbiota Therapy Severe Alcoholic Hepatitis</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>All patient diagnosis severe alcoholic hepatitis steroid ineligible , non responder intolerant Severe alcoholic hepatitis define Maddrey 's Discriminant Function Score ( 4.6 x ( PT test control ) ) + S.Bilirubin mg/dl 32 OR patient alcoholic hepatitis ( define AST : ALT ratio &gt; 2:1 ) present grade hepatic encephalopathy Conventional therapy define oral steroid therapy ( Wysolone Â® 40mg day 7 day ) Failure therapy define Lille Model Score ( http : //www.lillemodel.com ) &gt; 0.45 day 8 steroid therapy OR emergence complication steroid therapy intolerance steroid protocol ineligible steroid therapy . Ineligibility steroid therapy include Renal dysfunction , evidence active sepsis focus sepsis , gastro intestinal bleeding disseminate intravascular coagulation , steroid intolerance , steroid relate uncontrolled hyperglycemia precludes therapy , uncontrolled diabetes mellitus A Psychologist arrange recipient Fecal Transplant protocol psychological support throughout period one week , transplant procedure perform 1 . Healthy person willing faeces donation close family member 2 . The donor require give write consent faeces donation 3 . Once consent take , donor undergo follow screen measure : 1 . Clostridium difficile toxins A B EIA 2 . Routine bacterial culture enteric pathogen stool 3 . Ova parasites 4 . Blood serology virus human immunodeficiency virus [ HIV , type 1 2 ] HAV IgM , HBsAg , anti HCV Ab Active gastrointestinal bleeding Intracranial bleeding Multiorgan failure mechanical ventilation On high inotropic support Paralytic ileus Pregnancy Sepsis Failure provide consent Have abnormal bowel motion Have abdominal complaint Have symptom indicative irritable bowel syndrome Have extensive travel history predispose factor potentially transmittable disease Have chronic alcohol intake Have history substance abuse Are less 18 year 60 year age Have HIV Hepatitis Risk factor Have enteric infection Have inflammatory bowel disease history Have chronic constipation diarrhea Have prior abdominal surgery GI neoplasm Have Metabolic Syndrome Have Systemic Autoimmunity Have atopic disease Have food respiratory allergy Have chronic pain syndrome Have chronic Neurologic disorder Have Neurodevelopmental disorder Have antibiotic indication take within last 2 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>